{
    "Orphapacket": {
        "ORPHApacketId": "90157",
        "creationDate": "2025-12-08 06:52:43",
        "version": "1.3.42 / 4.1.8 [2025-03-03]",
        "copyright": "Orphanet (c) 2025",
        "ORPHAcode": "90157",
        "Label": "Drug-induced localized lipodystrophy",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_90157",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "Lipoatrophy caused by injected drug"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Drug-induced localized lipodystrophy is a rare acquired localized lipodystrophy characterized by the appearance of asymptomatic well-demarcated variably sized depressed lipoatrophic lesions secondary to subcutaneous intradermic or intramuscular drug injection including corticosteroids insulin human growth hormone and antibiotics. Skin coloration may vary from white or hypopigmented to reddish pinkish or violaceous. Epidermal atrophy may be also present."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "79088",
                        "Label": "Localized lipodystrophy"
                    }
                ]
            }
        ],
        "Phenotypes": [
            {
                "Phenotype": {
                    "HPOId": "HP:0100578",
                    "HPOTerm": "Lipoatrophy",
                    "HPOFrequency": "Obligate (100%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0003758",
                    "HPOTerm": "Reduced subcutaneous adipose tissue",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0007485",
                    "HPOTerm": "Absence of subcutaneous fat",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0000953",
                    "HPOTerm": "Hyperpigmentation of the skin",
                    "HPOFrequency": "Occasional (29-5%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0001010",
                    "HPOTerm": "Hypopigmentation of the skin",
                    "HPOFrequency": "Occasional (29-5%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0010783",
                    "HPOTerm": "Erythema",
                    "HPOFrequency": "Occasional (29-5%)"
                }
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "24336944[PMID]_17910713[PMID]_28979879[PMID]",
                    "PrevalenceType": "Cases/families",
                    "PrevalenceQualification": "Case(s)",
                    "PrevalenceClass": "no data",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            },
            {
                "Prevalence": {
                    "Source": "24336944[PMID]_17910713[PMID]_28979879[PMID]_ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            }
        ],
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "All ages"
                }
            ]
        }
    }
}